Skip to main content
SpringerLink
Log in

Belatacept nach Nierentransplantation unter Vermeidung von Steroiden

Belatacept after renal transplantation with avoidance of steroids

  • Für Sie gelesen
  • Published:
Der Nephrologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Vincenti F, Charpentier B, Vanrenterghem Y et al (2010) A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 10(3):535–546

    Article  PubMed  CAS  Google Scholar 

  2. Durrbach A, Pestana JM, Pearson T et al (2010) A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am J Transplant 10(3):547–557

    Article  PubMed  CAS  Google Scholar 

  3. Ekberg H, Tedesco-Silva H, Demirbas A et al (2007) Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 357(25):2562–2575

    Article  PubMed  CAS  Google Scholar 

  4. Buchler M, Caillard S, Barbier S et al (2007) Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids. Am J Transplant 7(11):2522–2531

    Article  PubMed  CAS  Google Scholar 

  5. Citterio F (2001) Steroid side effects and their impact on transplantation outcome. Transplantation 72(12 Suppl):S75–S80

    PubMed  CAS  Google Scholar 

  6. Matas AJ, Kandaswamy R, Gillingham KJ et al (2005) Prednisone-free maintenance immunosuppression: a 5-year experience. Am J Transplant 5(10):2473–2478

    Article  PubMed  Google Scholar 

  7. Ferguson R, Grinyó J, Vincenti F et al (2011) Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients. Am J Transplant 11(1):66–76

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. III. Medizinische Klinik, Universitätsklinikum Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Deutschland

    L.V. Schewior

Authors
  1. L.V. Schewior
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L.V. Schewior.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schewior, L. Belatacept nach Nierentransplantation unter Vermeidung von Steroiden. Nephrologe 6, 159–161 (2011). https://doi.org/10.1007/s11560-010-0515-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11560-010-0515-1

Search

Navigation